Scientists find a potential treatment to prevent diabetes and obesity

A molecule called interleukin-6 has opened new doors for the creation of new drugs against obesity and diabetes. These are the conclusions of an international project which has had the participation of researchers from Vitagenes, a company which forms part of the Campus program promoted by the University of Granada (UGR) and situated in the Technological Park of Health Sciences (PTS).

Read more

Mayo Clinic discovery may help diabetic gastric problem

Mayo Clinic researchers have found what may provide a solution to one of the more troubling complications of diabetes — delayed gastric emptying or gastroparesis. The researchers showed in animal models that a red blood cell derivative increases production of a key molecule, normalizing the digestive process. The findings appear in the current online issue of the journal Gastroenterology (http://www.gastrojournal.org/).

Read more

‘Friendly’ Bacteria Protect Against Type 1 Diabetes

In a dramatic illustration of the potential for microbes to prevent disease, researchers at Yale University and the University of Chicago showed that mice exposed to common stomach bacteria were protected against the development of Type I diabetes.

Read more

New once-a-week treatment for type 2 diabetes developed by Mount Sinai researcher

In a study published by the Lancet journal today, Toronto researcher Dr. Daniel Drucker reported that a new once-weekly treatment for type 2 diabetes could replace the more common twice-daily injection.

Read more